Atıf İçin Kopyala
Gol M., Saygili U., KOYUNCUOĞLU ÜLGÜN M., Uslu T.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, cilt.35, sa.3, ss.429-433, 2009 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
35
Sayı:
3
-
Basım Tarihi:
2009
-
Doi Numarası:
10.1111/j.1447-0756.2008.00945.x
-
Dergi Adı:
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.429-433
-
Anahtar Kelimeler:
methotrexate, mice, ovary, GESTATIONAL TROPHOBLASTIC TUMORS, GONADAL-FUNCTION, CHEMOTHERAPY, CYCLOPHOSPHAMIDE, OSTEOSARCOMA, PREGNANCY, LEUKEMIA, SARCOMA, DISEASE, RATES
-
Dokuz Eylül Üniversitesi Adresli:
Evet
Özet
Objective: High-dose methotrexate (MTX) is one of the most prescribed agents in many malignant diseases affecting girls and young women of reproductive ages. This animal study directly measures the primordial follicle loss following exposure to high-dose MTX.